Selective Activation of Cannabinoid CB(2) Receptors Suppresses Neuropathic Nociception Induced by Treatment with the Chemotherapeutic Agent Paclitaxel in Rats

Podobne knjige/članki

• Activation of cannabinoid CB(1) and CB(2) receptors suppresses neuropathic nociception evoked by the chemotherapeutic agent vincristine in rats
  od: Rahn, E J, et al.
  Izdano: (2007)
• Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery
  od: Rahn, Elizabeth J, et al.
  Izdano: (2014)
• Activation of peripheral cannabinoid CB(1) and CB(2) receptors suppresses the maintenance of inflammatory nociception: a comparative analysis
  od: Gutierrez, T, et al.
  Izdano: (2006)
• Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain
  od: Gutierrez, Tannia, et al.
  Izdano: (2011)
• Pharmacological characterization of AM1710, a putative cannabinoid CB(2) agonist from the cannabilactone class: Antinociception without central nervous system side-effects
  od: Rahn, Elizabeth J., et al.
  Izdano: (2011)